Actively Recruiting
Amyotrophic Lateral Sclerosis Registry in Thailand
Led by Chulalongkorn University · Updated on 2025-09-16
100
Participants Needed
1
Research Sites
304 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective, observational, multicenter registry designed to collect comprehensive clinical, genetic, and outcome data from patients diagnosed with amyotrophic lateral sclerosis (ALS) across Thailand. The registry will establish a national dataset to describe epidemiology, clinical presentation, progression, and treatment outcomes, and will serve as a platform for future clinical and translational research.
CONDITIONS
Official Title
Amyotrophic Lateral Sclerosis Registry in Thailand
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of ALS according to El Escorial or Gold Coast criteria
- Age 65 18 years
- Ability and willingness to provide informed consent
You will not qualify if you...
- Patients unwilling to provide informed consent
- Patients with alternative diagnoses mimicking ALS
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
King Chulalongkorn Memorial hospital, The Thai Red Cross Society
Pathum Wan, Bangkok, Thailand, 10330
Actively Recruiting
Research Team
J
Jakkrit Amornvit, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here